Henry I. Miller


Henry I. Miller, MS, MD, was the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution. His research focused on public policy toward science and technology, encompassing a number of areas, including pharmaceutical development, genetic engineering in agriculture, models for regulatory reform, and the emergence of new viral diseases.

Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner and the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the US government. As a government official, Miller received numerous awards and citations.

During his time at the Hoover Institution, Miller has become well known not only for his contributions to scholarly journals but also for his articles and books that make science, medicine, and technology accessible. His work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Miller has published extensively in a wide spectrum of scholarly journals and popular publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, the Guardian, Defining Ideas, and the Financial Times. He was a regulator contributor to Forbes.com and frequently appeared on the nationally syndicated radio programs of John Batchelor and Lars Larson.

Miller was selected by the editors of Nature Biotechnology as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. He serves on numerous editorial boards.

Filter By:



Recent Commentary

Regulatory Overdose

by Henry I. Millervia Hoover Digest
Sunday, July 30, 2000

Gene therapy offers enormous potential for the treatment of serious illness. What is the government doing about it? Thwarting researchers. By Hoover fellow Henry I. Miller.

Global Food Fight

by Henry I. Millervia Hoover Digest
Sunday, January 30, 2000

With concern over genetically altered food already at levels of near hysteria in Europe, the anti-biotechnology lobby is now focusing its campaign of disinformation on the United States. Hoover fellow Henry I. Miller explains why we have nothing to fear from high-tech food.

To America's Health: A Proposal to Reform the Food and Drug Administration

by Henry I. Millervia Books by Hoover Fellows
Saturday, January 1, 2000

A government monopoly over drug regulation is not sacrosanct. This hard-hitting book describes the current regulation of drugs by the FDA and proposes a model for fundamental, yet workable, reform—including an innovative proposal for drug testing and certification review.

FIELD OF GENES: Genetically Modified Foods

with Henry I. Miller, Walter Anderson, Peggy Lemauxvia Uncommon Knowledge
Thursday, September 2, 1999

Genetically modified crops and foods are already big business. But are they safe? Have the giant agribusiness companies that have rushed them into the fields and into our stores overlooked potential dangers posed by genetically engineered crops? Even if scientists do believe these crops are safe, how do they convince a skeptical public?

Farmers: Beware Drought, Pestilence, and the EPA

by Henry I. Millervia Hoover Digest
Friday, July 30, 1999

On the one hand, the federal government provides farmers with subsidies worth billions every year. On the other, it imposes arcane, burdensome regulations on the development of new crops, costing farmers billions every year. Hoover fellow Henry I. Miller explains how the government giveth and the government taketh away.

Choke Hold

by Henry I. Millervia Hoover Digest
Friday, April 30, 1999

The biotech industry is choking on FDA regulations. Hoover Fellow Henry I. Miller attempts a Heimlich maneuver.

Sick Process

by Henry I. Millervia Hoover Digest
Saturday, January 30, 1999

Who would have thought that American bureaucrats could learn about efficiency from . . . European bureaucrats? Hoover fellow Henry I. Miller explains why the Food and Drug Administration should imitate its counterpart in London.

The Battle over the Battle of the Bulge

by Henry I. Millervia Hoover Digest
Friday, October 30, 1998

A new fat-free cooking oil called olestra could radically reduce fat consumption in American diets. Why is the government restricting its use? Hoover fellow Henry I. Miller reports.

this is an image

Brave New Beauty

by Henry I. Millervia Hoover Digest
Thursday, July 30, 1998

Advances in genetic engineering may make it possible for people to alter their genetic structure for purely cosmetic purposes. Should the government intervene? Hoover fellow Henry I. Miller thinks not.

March of the Troglodytes

by Henry I. Millervia Hoover Digest
Thursday, April 30, 1998

Scientific illiterates are attempting to bury biotechnology. By Hoover fellow Henry I. Miller.